Draegerwerk AG KGaA (HAM:DRW8) ROCE %: 3.75% (As of Mar. 2026)


HAM:DRW8 Draegerwerk AG & Co KGaA HAM:DRW8
75 GF Score
Price €70.20
GF Value €47.88
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Draegerwerk AG KGaA ROCE %?

Draegerwerk AG KGaA HAM:DRW8 75 ROCE % is 3.75% as of Mar. 2026. GuruFocus rates HAM:DRW8 with a GF Score™ of 75/100 and a GF Value™ of €47.88 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Draegerwerk AG KGaA's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.75%.

Draegerwerk AG KGaA  (HAM:DRW8) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Draegerwerk AG KGaA ROCE % Related Terms

Draegerwerk AG KGaA ROCE % Historical Data

* Premium members only.

The historical data trend for Draegerwerk AG KGaA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Draegerwerk AG KGaA ROCE % Chart

Draegerwerk AG KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.58 -3.86 8.71 9.67 11.24

Draegerwerk AG KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 4.29 11.81 30.31 3.75
HAM:DRW8
75GF Score
Draegerwerk AG & Co KGaA HAM:DRW8
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Draegerwerk AG KGaA ROCE % Calculation

Draegerwerk AG KGaA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=243.483/( ( (3093.435 - 978.48) + (3163.092 - 944.409) )/ 2 )
=243.483/( (2114.955+2218.683)/ 2 )
=243.483/2166.819
=11.24 %

Draegerwerk AG KGaA's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=83.568/( ( (3163.092 - 944.409) + (3165.837 - 921.647) )/ 2 )
=83.568/( ( 2218.683 + 2244.19 )/ 2 )
=83.568/2231.4365
=3.75 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.75% mean?
Draegerwerk AG KGaA (HAM:DRW8) has a ROCE % of 3.75% as of Mar. 2026.
Is Draegerwerk AG KGaA's ROCE % too high?
Draegerwerk AG KGaA's current ROCE % is 3.75%. The Medical Devices & Instruments industry median ROCE % is 2.23. Draegerwerk AG KGaA's value of 3.75% is 68.2% above this industry median. Overall, Draegerwerk AG KGaA has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's ROCE % compare to ABT and SYK?
Draegerwerk AG KGaA's ROCE % of 3.75% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Draegerwerk AG KGaA's value of 3.75% is 68.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current ROCE % of 3.75% is 68.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current ROCE % is 3.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (HAM:DRW8) is currently considered Significantly Overvalued. The stock's GF Value™ is €47.88, compared to a current price of €70.20 — trading 46.6% above its estimated fair value. The current ROCE % is 3.75% and 68.2% above the Medical Devices & Instruments industry median of 2.23. Draegerwerk AG KGaA's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Draegerwerk AG KGaA (HAM:DRW8), the current ROCE % is 3.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Draegerwerk AG KGaA (HAM:DRW8) Overvalued in 2026?

Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued. The current stock price of €70.20 is trading 46.6% above its estimated GF Value™ of €47.88. GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.

Key valuation signals for HAM:DRW8:

  • ROCE %: 3.75%
  • GF Value™: €47.88 vs. price of €70.20 (46.6% above fair value)
  • GF Score™: 75/100 with 5 warning signs
  • Industry Position: 68.2% above the Medical Devices & Instruments median

No single metric tells the full story. See the HAM:DRW8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Draegerwerk AG KGaA Business Description

Address Moislinger Allee 53 - 55, Lubeck, DEU, 23542
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
75GF Score

Get the complete analysis for HAM:DRW8

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.20
Price
€47.88
GF Value